用于癌症早期检测的生物标志物开发阶段。 - Suppr

Suppr

超能文献

Phases of biomarker development for early detection of cancer.

作者信息

Pepe M S, Etzioni R, Feng Z, Potter J D, Thompson M L, Thornquist M, Winget M, Yasui Y

机构信息

Department of Biostatistics, University of Washington, Seattle 98195-7232, USA.

出版信息

J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61. doi: 10.1093/jnci/93.14.1054.

DOI:10.1093/jnci/93.14.1054

PMID:11459866

Abstract

摘要

相似文献

Phases of biomarker development for early detection of cancer.

J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61. doi: 10.1093/jnci/93.14.1054.

Improving the biomarker pipeline to develop and evaluate cancer screening tests.

J Natl Cancer Inst. 2009 Aug 19;101(16):1116-9. doi: 10.1093/jnci/djp186. Epub 2009 Jul 2.

Screening.

Eur Respir J Suppl. 2003 Jan;39:3s-15s. doi: 10.1183/09031936.03.00406003.

Evaluating markers for the early detection of cancer: overview of study designs and methods.

Clin Trials. 2006;3(1):43-56. doi: 10.1191/1740774506cn130oa.

The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer.

J Natl Cancer Inst. 2003 Apr 2;95(7):511-5. doi: 10.1093/jnci/95.7.511.

Biomarkers as surrogates for cancer development.

Curr Oncol Rep. 2000 May;2(3):242-50. doi: 10.1007/s11912-000-0074-0.

[Biomarker screening for early detection of cancer].

Dtsch Med Wochenschr. 2013 Jan;138(1-2):43-5. doi: 10.1055/s-0032-1327370. Epub 2012 Dec 18.

Design issues in cancer screening trials.

Stat Methods Med Res. 2010 Oct;19(5):451-61. doi: 10.1177/0962280209359846. Epub 2010 May 4.

Screening with tumor markers: critical issues.

Mol Biotechnol. 2002 Feb;20(2):153-62. doi: 10.1385/MB:20:2:153.

The case for early detection.

Nat Rev Cancer. 2003 Apr;3(4):243-52. doi: 10.1038/nrc1041.

引用本文的文献

Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma.

Br J Cancer. 2025 Sep 3. doi: 10.1038/s41416-025-03167-2.

Construction and validation of a necroptosis-related lncRNA signature for predicting the prognosis of gastrointestinal cancer patients.

Front Immunol. 2025 Aug 14;16:1591252. doi: 10.3389/fimmu.2025.1591252. eCollection 2025.

Design aspects for prognostic factor studies.

BMJ Open. 2025 Aug 31;15(8):e095065. doi: 10.1136/bmjopen-2024-095065.

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology. 2025 Sep 1;82(3):794-809. doi: 10.1097/HEP.0000000000001203. Epub 2024 Dec 18.

Liquid Biopsy: Current advancements in clinical practice for bladder cancer.

J Liq Biopsy. 2025 Jul 8;9:100310. doi: 10.1016/j.jlb.2025.100310. eCollection 2025 Sep.

Liquid biopsy-based multi-cancer early detection: an exploration road from evidence to implementation.

Sci Bull (Beijing). 2025 Sep 15;70(17):2852-2867. doi: 10.1016/j.scib.2025.06.030. Epub 2025 Jun 24.

T cell receptor profiling of blood to detect lung cancer.

Cancer Immunol Res. 2025 Jul 1. doi: 10.1158/2326-6066.CIR-24-1109.

H3K18 lactylation in pancreatic cancer: promising yet unproven ‒ a call for validation.

Clinics (Sao Paulo). 2025 Jun 24;80:100715. doi: 10.1016/j.clinsp.2025.100715.

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.

Clin Cancer Res. 2025 Aug 14;31(16):3483-3493. doi: 10.1158/1078-0432.CCR-24-2525.

Detection of Circulating mRNA Variants in Hepatocellular Carcinoma Patients Using Targeted RNAseq.

Liver Cancer. 2025 Apr 4:1-32. doi: 10.1159/000545366.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Phases of biomarker development for early detection of cancer.

J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61. doi: 10.1093/jnci/93.14.1054.

Improving the biomarker pipeline to develop and evaluate cancer screening tests.

J Natl Cancer Inst. 2009 Aug 19;101(16):1116-9. doi: 10.1093/jnci/djp186. Epub 2009 Jul 2.

Screening.

Eur Respir J Suppl. 2003 Jan;39:3s-15s. doi: 10.1183/09031936.03.00406003.

Evaluating markers for the early detection of cancer: overview of study designs and methods.

Clin Trials. 2006;3(1):43-56. doi: 10.1191/1740774506cn130oa.

The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer.

J Natl Cancer Inst. 2003 Apr 2;95(7):511-5. doi: 10.1093/jnci/95.7.511.

Biomarkers as surrogates for cancer development.

Curr Oncol Rep. 2000 May;2(3):242-50. doi: 10.1007/s11912-000-0074-0.

[Biomarker screening for early detection of cancer].

Dtsch Med Wochenschr. 2013 Jan;138(1-2):43-5. doi: 10.1055/s-0032-1327370. Epub 2012 Dec 18.

Design issues in cancer screening trials.

Stat Methods Med Res. 2010 Oct;19(5):451-61. doi: 10.1177/0962280209359846. Epub 2010 May 4.

Screening with tumor markers: critical issues.

Mol Biotechnol. 2002 Feb;20(2):153-62. doi: 10.1385/MB:20:2:153.

The case for early detection.

Nat Rev Cancer. 2003 Apr;3(4):243-52. doi: 10.1038/nrc1041.

引用本文的文献

Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma.

Br J Cancer. 2025 Sep 3. doi: 10.1038/s41416-025-03167-2.

Construction and validation of a necroptosis-related lncRNA signature for predicting the prognosis of gastrointestinal cancer patients.

Front Immunol. 2025 Aug 14;16:1591252. doi: 10.3389/fimmu.2025.1591252. eCollection 2025.

Design aspects for prognostic factor studies.

BMJ Open. 2025 Aug 31;15(8):e095065. doi: 10.1136/bmjopen-2024-095065.

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology. 2025 Sep 1;82(3):794-809. doi: 10.1097/HEP.0000000000001203. Epub 2024 Dec 18.

Liquid Biopsy: Current advancements in clinical practice for bladder cancer.

J Liq Biopsy. 2025 Jul 8;9:100310. doi: 10.1016/j.jlb.2025.100310. eCollection 2025 Sep.

Liquid biopsy-based multi-cancer early detection: an exploration road from evidence to implementation.

Sci Bull (Beijing). 2025 Sep 15;70(17):2852-2867. doi: 10.1016/j.scib.2025.06.030. Epub 2025 Jun 24.

T cell receptor profiling of blood to detect lung cancer.

Cancer Immunol Res. 2025 Jul 1. doi: 10.1158/2326-6066.CIR-24-1109.

H3K18 lactylation in pancreatic cancer: promising yet unproven ‒ a call for validation.

Clinics (Sao Paulo). 2025 Jun 24;80:100715. doi: 10.1016/j.clinsp.2025.100715.

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.

Clin Cancer Res. 2025 Aug 14;31(16):3483-3493. doi: 10.1158/1078-0432.CCR-24-2525.

Detection of Circulating mRNA Variants in Hepatocellular Carcinoma Patients Using Targeted RNAseq.

Liver Cancer. 2025 Apr 4:1-32. doi: 10.1159/000545366.